Advances in acute myeloid leukemia

LF Newell, RJ Cook - Bmj, 2021‏ - bmj.com
Acute myeloid leukemia (AML) is an uncommon but potentially catastrophic diagnosis with
historically high mortality rates. The standard of care treatment remained unchanged for …

Antibiotic resistance in the patient with cancer: Escalating challenges and paths forward

AK Nanayakkara, HW Boucher… - CA: a cancer journal …, 2021‏ - Wiley Online Library
Infection is the second leading cause of death in patients with cancer. Loss of efficacy in
antibiotics due to antibiotic resistance in bacteria is an urgent threat against the continuing …

Cancer chemotherapy resistance: Mechanisms and recent breakthrough in targeted drug delivery

F Davodabadi, SF Sajjadi, M Sarhadi… - European Journal of …, 2023‏ - Elsevier
Conventional chemotherapy, one of the most widely used cancer treatment methods, has
serious side effects, and usually results in cancer treatment failure. Drug resistance is one of …

Antimicrobial prophylaxis for adult patients with cancer-related immunosuppression: ASCO and IDSA clinical practice guideline update

RA Taplitz, EB Kennedy, EJ Bow, J Crews… - Journal of Clinical …, 2018‏ - ascopubs.org
Purpose To provide an updated joint ASCO/Infectious Diseases Society of America (IDSA)
guideline on antimicrobial prophylaxis for adult patients with immunosuppression …

[HTML][HTML] WHO's essential medicines and AWaRe: recommendations on first-and second-choice antibiotics for empiric treatment of clinical infections

L Moja, V Zanichelli, D Mertz, S Gandra… - Clinical Microbiology …, 2024‏ - Elsevier
Abstract The WHO Model List of Essential Medicines (EML) prioritizes medicines that have
significant global public health value. The EML can also deliver important messages on …

How I prevent infections in patients receiving CD19-targeted chimeric antigen receptor T cells for B-cell malignancies

JA Hill, SK Seo - Blood, The Journal of the American Society of …, 2020‏ - ashpublications.org
Adoptive immunotherapy using B-cell–targeted chimeric antigen receptor (CAR)-modified T
cells to treat hematologic malignancies is transforming cancer care for patients with …

Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America

DL Stevens, AL Bisno, HF Chambers… - Clinical infectious …, 2014‏ - academic.oup.com
We have examined the effect of profound hypothermia on gut mucosal perfusion in 20
infants, aged 1.4-45 weeks, requiring cardiopulmonary bypass (CPB). After induction of …

Treatment of infections caused by multidrug-resistant gram-negative bacteria: Report of the British society for antimicrobial chemotherapy/healthcare infection society …

PM Hawkey, RE Warren, DM Livermore… - Journal of …, 2018‏ - academic.oup.com
Abstract The Working Party makes more than 100 tabulated recommendations in
antimicrobial prescribing for the treatment of infections caused by multidrug-resistant (MDR) …

[HTML][HTML] Diabetes and cancer: risk, challenges, management and outcomes

RK Shahid, S Ahmed, D Le, S Yadav - Cancers, 2021‏ - mdpi.com
Simple Summary Diabetes mellitus is a common disease in patients with cancer. It is a risk
factor for certain cancers such as pancreatic, liver, colon, breast, and endometrial cancer …

Nanoparticle-based drug delivery system: a patient-friendly chemotherapy for oncology

L Yan, J Shen, J Wang, X Yang, S Dong… - Dose …, 2020‏ - journals.sagepub.com
Chemotherapy is widely used to treat cancer. The toxic effect of conventional
chemotherapeutic drugs on healthy cells leads to serious toxic and side effects of …